29 June 2022 - Having worked in healthcare most of my life, very little surprises me. But four years ago, I was shocked by the unfiltered honesty of one drug company CEO.

Asked to explain why he raised the price of an antibiotic by more than 400%, Nirmal Mulye, CEO of Nostrum Laboratories, told the Financial Times: “I think it’s a moral requirement to make money when you can … to sell the product for the highest price.”

Read Forbes article